Reuters -- Skystar Bio-Pharmaceutical Co (SKBID.O), a China-based producer of veterinary healthcare products, forecast lower total vaccine revenue due to a delay in the build-out of its vaccine facility, sending its shares down 16 percent.
Reuters -- Skystar Bio-Pharmaceutical Co (SKBID.O), a China-based producer of veterinary healthcare products, forecast lower total vaccine revenue due to a delay in the build-out of its vaccine facility, sending its shares down 16 percent.
